Time lost for diagnostics of lung carcinoma related to disease stage and prognosis

G. D. Radosavljevic - Asic (Belgrade, Serbia)

Source: Annual Congress 2004 - Diagnostic management of lung cancer, clinical features
Session: Diagnostic management of lung cancer, clinical features
Session type: Thematic Poster Session
Number: 1915
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. D. Radosavljevic - Asic (Belgrade, Serbia). Time lost for diagnostics of lung carcinoma related to disease stage and prognosis. Eur Respir J 2004; 24: Suppl. 48, 1915

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The risk of distant metastases and prognosis prediction in early stage squamous cell lung cancer (SqCLC) by means of 3 microRNAs expression assessment
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011


Features affecting stages of patients with lung cancer at diagnosis
Source: Eur Respir J 2005; 26: Suppl. 49, 536s
Year: 2005

Predictors of major serious manifestations in the terminal stage of lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Interleukine-17A implicated in survival outcome of patients with late stage lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Time in lung cancer diagnosis and its prognostic implication
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018


Age and stage at presentation in lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Delays in the diagnosis and treatment of primary lung cancer: are longer delays associated with advanced pathological stage?
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017

Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma?
Source: Eur Respir J 2014; 43: 1240-1242
Year: 2014


Symptoms, signs and staging of lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=86
Year: 2001

Analysis of risk factors for brain metastasis in locally advanced stage non-small cell carcinoma
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010

Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018

Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up?
Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020
Year: 2020



Treatment of early (stage I/II) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005


The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Analysis of lung adenocarcinoma in patients aged 70 and over: The viewpoint of clinical stage, therapeutic modality and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis
Source: Eur Respir J 2008; 31: 854-859
Year: 2008



Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Pattern of relapse in stage I N0 non small cell lung cancer
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009


Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017